Slama Laurence, Jacobson Lisa P, Li Xiuhong, Palella Frank J, Margolick Joseph B, Kingsley Lawrence A, Wiley Dorothy J, Pialoux Gilles, Dobs Adrian S, Brown Todd T
*Division of Infectious Diseases, Tenon Hospital, Pierre and Marie Curie University, Paris, France;†Division of Infectious Diseases, Feinberg School of Medicine, Northwestern University, Chicago, IL;Departments of ‡Epidemiology;§Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD;‖Department of Infectious Diseases and Microbiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA;¶Division of Translational Science, School of Nursing, UCLA, Los Angeles, CA; and#Division of Endocrinology, Diabetes and Metabolism, Johns Hopkins University School of Medicine, Baltimore, MD.
J Acquir Immune Defic Syndr. 2016 Jan 1;71(1):57-64. doi: 10.1097/QAI.0000000000000821.
Aging in males is associated with lower testosterone levels and a decrease in diurnal variation of testosterone secretion. Cross-sectional studies have shown lower than expected testosterone levels among HIV-infected men, but whether age-related changes in serum testosterone differ by HIV serostatus are not known.
HIV-infected men from the Multicenter AIDS Cohort Study (MACS), age ≥ 45 years at highly active antiretroviral therapy initiation, who had ≥ 2 samples from the subsequent 10 years, were matched to HIV-uninfected men by age, race, MACS site, and calendar time of samples. Linear mixed-effects regression models were used to determine whether free testosterone (FT) and its rate of change differed by HIV serostatus.
One hundred eighty-two HIV-infected and 267 HIV-uninfected men were included, median age: 48.8 years (interquartile range: 45.8-53.4), median numbers of FT measurements per participant 4 (interquartile range: 3-5), 65% were drawn in the adjusted morning (AM). Mean-adjusted FT levels were lower among HIV-infected than HIV-uninfected men in AM samples {-6.1 ng/dL [95% confidence interval (CI): -9.8 to -2.4], P = 0.001}, but not in afternoon samples [-1.7 ng/dL (-6.0 to 2.6), P = 0.441]. The rate of FT decline with age did not differ by HIV serostatus: 9.2 ng/dL (95% CI: -13.4 to -5.0) per 10 years for HIV-infected vs. 7.9 ng/dL (95% CI: -10.2 to -5.5) for HIV-uninfected men, P = 0.578.
FT decreased similarly with increasing age regardless of HIV serostatus. The lower AM, but not adjusted afternoon, FT levels among HIV-infected men compared with HIV-uninfected men suggest a loss of diurnal variation in FT levels among HIV-infected men.
男性衰老与睾酮水平降低以及睾酮分泌的昼夜变化减少有关。横断面研究显示,感染艾滋病毒的男性睾酮水平低于预期,但血清睾酮与年龄相关的变化是否因艾滋病毒血清学状态而异尚不清楚。
来自多中心艾滋病队列研究(MACS)的感染艾滋病毒的男性,在开始高效抗逆转录病毒治疗时年龄≥45岁,且在随后10年中有≥2份样本,按照年龄、种族、MACS研究地点和样本采集的日历时间与未感染艾滋病毒的男性进行匹配。使用线性混合效应回归模型来确定游离睾酮(FT)及其变化率是否因艾滋病毒血清学状态而异。
纳入了182名感染艾滋病毒的男性和267名未感染艾滋病毒的男性,中位年龄:48.8岁(四分位间距:45.8 - 53.4),每位参与者FT测量的中位数为4次(四分位间距:3 - 5),65%的样本是在调整后的早晨(AM)采集的。在AM样本中,感染艾滋病毒的男性经均值调整后的FT水平低于未感染艾滋病毒的男性{-6.1 ng/dL [95%置信区间(CI):-9.8至-2.4],P = 0.001},但在下午样本中并非如此[-1.7 ng/dL(-6.0至2.6),P = 0.441]。FT随年龄下降的速率不因艾滋病毒血清学状态而异:感染艾滋病毒的男性每10年下降9.2 ng/dL(95% CI:-13.4至-5.0),未感染艾滋病毒的男性为7.9 ng/dL(95% CI:-10.2至-5.5),P = 0.578。
无论艾滋病毒血清学状态如何,FT均随年龄增长而以相似的方式下降。与未感染艾滋病毒的男性相比,感染艾滋病毒的男性早晨(AM)的FT水平较低,但下午经调整后的FT水平并无差异,这表明感染艾滋病毒的男性FT水平的昼夜变化消失。